Pan-Asian Drug Development

The Asian pharmaceutical market is a collection of widely disparate systems. From the perspective of U.S. and European pharmaceutical companies, the task of developing and commercializing NCEs in Asia, on a country by country basis, can prove time and cost-prohibitive.

To address these challenges, Velos has synthesized a virtual, pan-Asian drug development enterprise by aggregating the capabilities of local companies across the Asia Pacific region. We then centralize business development, licensing and project management. The result: scale, flexibility and depth.